Pretoria, 29 May 2024 –The South African Health Products Regulatory Authority (SAHPRA) has attained its ISO 9001:2015 certification following a rigorous audit by the South African Bureau of Standards (SABS), a milestone that serves as a testament to the implementation of an effective and robust...
Pretoria, South Africa, 28 April 2024 – The South African Health Products Regulatory Authority (SAHPRA) and the Botswana Medicines Regulatory Authority (BoMRA) have signed a memorandum of understanding (MoU) that will see the two regulators partner on various areas to improve access to new medicines...
Pretoria, 13 April 2024 – On 10 April 2024, the South African Health Products Regulatory Authority (SAHPRA) received a report from the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) regarding the detection of high levels of diethylene glycol in a batch...
Kigali - Rwanda, 12 April 2024 – The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MoU) with the Rwanda Food and Drug Authority (Rwanda FDA). The MOU between SAHPRA and Rwanda FDA will allow the regulators to develop a cooperative...
The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration with Pharmacometrics Africa and the Department of Pharmacy and Pharmacology at the University of Witwatersrand, is pleased to announce the third cohort of graduates who successfully completed the short course for Clinical Assessors within African...
Pretoria, 11 March 2024 – On 05 January 2023, the COVID Care Alliance NPC and other applicants brought an urgent court application against the South African Health Products Regulatory Authority (SAHPRA), including the President of the Republic of South Africa and others to prevent people from...
Pretoria, 19 February 2024 – The Department of Health has noted a misleading voice-note making rounds on social media platforms claiming that people who vaccinated against COVID-19 are dying due to the vaccine. The voice-note promotes the use of an unregistered, over-the-counter product called “Nature`s Choice...
Pretoria, 12 January 2024 – The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MoU) with the Medicines Control Authority of Zimbabwe (MCAZ). The MoU between SAHPRA and MCAZ will allow the regulators to develop a cooperative partnership towards ensuring access...
Pretoria, 19 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) is aware of the product Lubri-A (Sterile Lubricating Jelly) manufactured by Electro-Spyres, classified as Class B medical device and currently being distributed across the country. SAHPRA has been informed of multiple complaints received...
Pretoria, 14 December 2023 -The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration with Pharmacometrics Africa and the Department of Pharmacy and Pharmacology at the University of Witwatersrand, is responsive to the evolving and advancing healthcare technology innovation by developing relevant training for its...
